Metabolic Disorders - Cengage3 © 2007 Thomson - Wadsworth Metabolic Disorders • Inheritance 9Most...
Transcript of Metabolic Disorders - Cengage3 © 2007 Thomson - Wadsworth Metabolic Disorders • Inheritance 9Most...
1
© 2007 Thomson - Wadsworth
Metabolic Disorders
Chapter 28
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
2
© 2007 Thomson - Wadsworth
Metabolic Disorders
• Inborn errors of metabolism – group of diseases that affect a wide variety of metabolic processes; defective processing or transport of amino acids, fatty acids, sugars or metals caused by a defect in the activity of an enzyme
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
3
© 2007 Thomson - Wadsworth
Metabolic Disorders
• InheritanceMost inborn errors are autosomalrecessive• Carrier parents have a 25% chance of an
affected childMutations – permanent, transmissible changes in the genetic material• Differences in degree of stability and
activity of enzyme• Severity described by time of onset• Classical form most severe
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
4
© 2007 Thomson - Wadsworth
Metabolic Disorders
• Impaired Metabolism -Pathophysiology
Deficient or absent enzyme activity orChanges in binding site of cofactorPrecursors accumulated d/t block or impaired feedback inhibitionToxic metabolites produced as a result of the build upOr deficiency of needed end productSecondary nutritional deficiencies
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
5
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
6
© 2007 Thomson - Wadsworth
Metabolic Disorders
• Diagnosis/ Newborn ScreeningNonselective screening – screening all newborns for a limited number of common inborn errorsSelective – testing of an individual known to be at increased risk (e.g. sibling)All states screen for PKU, variability in other disorders screenedTandem mass spectroscopy – allows clinicians to screen for > 30 disorders
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
7
© 2007 Thomson - Wadsworth
Metabolic Disorders• Clinical manifestations
Summarized in Table 28.1Usually appear 24 hours or more after birth, attributed to ingestion of precursor substrate of defective enzymeCNS symptoms, poor growth, failure to thrive, developmental delays, specific neurological deficitsMay have blatant signs (i.e. unusual odor)
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
8
© 2007 Thomson - Wadsworth
Metabolic Disorders
• Clinical manifestations – diagnosisLaboratory studies – see Table 28.2Routine • Hypoglycemia, acid-base balance,
hyperammonemia, ketosis
Specialized studies• Require special lab• Directed analysis for amino acids or
organic acids
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
9
© 2007 Thomson - Wadsworth
Metabolic Disorders
• Approaches to TreatmentAcute therapy• Correction of acid-base balance and
hydration of immediate importance• Maintenance of adequate kcal to prevent
tissue catabolism• Offending metabolites restricted
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
10
© 2007 Thomson - Wadsworth
Metabolic Disorders
• Approaches to TreatmentChronic Therapy• Restriction of precursors• Replacement of end products• Providing alternate substrates for
metabolism• Use of scavenger drugs to remove toxic
by-products• Supplementation of vitamins or other
cofactors
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
11
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• Phenylketonuria (PKU)• Isovaleric acidemia (IVA)• Maple syrup urine disease (MSUD)• Others - see Table 28.3
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
12
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• Phenylketonuria (PKU) – most common
Absence of phenylalanine hydroxylaseenzymeInability to convert phenylalanine to tyrosineTyrosine becomes conditionally essential See Fig. 28.2
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
13
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
14
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• Phenylketonuria (PKU) Results in metal retardation, severe behavioral problems, seizures, eczemaMusty or mousy odorToxic to brain – demyelination of white matterDecreased production of serotonin, epinephrine, norepinephrine, dopamine, GABA
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
15
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• PKU – Nutrition InterventionsRestriction of dietary proteinSynthetic formula supplying all essential amino acids except offending amino acidsBlood phenylalanine target levels more restrictive for children up to age 12
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
16
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• PKU – Nutrition InterventionsAssess kcal and protein needsAmount of allowed phenylalanine determined by enzymatic activity and blood levelsAllow as much protein as possible for adequate growth from fruits, vegetables, limited amounts of grainsBalance provided by metabolic formulas
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
17
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
18
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• PKU – Nutritional ConcernsRisk for nutritional deficienciesGrowth retardationBone statusAmino acid deficienciesOverrestrictionMetabolic control during pregnancy
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
19
© 2007 Thomson - Wadsworth
Amino Acid Disorders
• PKU – Adjunct TherapiesAntibioticsCarnitineSodium benzoateSodium phenylbutyrate
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
20
© 2007 Thomson - Wadsworth
Urea Cycle Disorders
• Impaired capacity to excrete nitrogen in the form of urea
• Cascade of enzymatic reactions which converts ammonia to urea can be blocked
• Or a depletion of an amino acid essential to the function of the cycle can result
• Causing hyperammonemia• See Fig. 28.3
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
21
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
22
© 2007 Thomson - Wadsworth
Urea Cycle Disorders
• Hyperammonia may cause loss of appetite, cyclical vomiting, lethargy, learning difficulties, behavioral abnormalities, severe retardation
• May require daily assistance, tube feedings, and wheelchairs
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
23
© 2007 Thomson - Wadsworth
Urea Cycle Disorders
• Acute Treatment HemodialysisSodium benzoate and sodium phenylacetate to scavenge excess ammoniaIV fluids, avoiding overhydrationCaloric supplementationGlucose, intralipidsComplete protein restriction for 24-48 hours
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
24
© 2007 Thomson - Wadsworth
Urea Cycle Disorders
• Nutrition InterventionsProtein adjustment to account for severity, age, growth rate, and individual preferences without any extra, see Table 28.7Supplemental arginine for mostMay use essential amino acid mixture to replace natural sources25-30% of protein intake should be essential amino acids
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
25
© 2007 Thomson - Wadsworth
Urea Cycle Disorders
• Nutrition ConcernsAmino acid intake must be balancedRisk of micronutrient deficiency• Iron, zinc
Adequate energy intakeNutrition support may be neededContinuous monitoringSee flow sheet example – Table 28.8
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
26
© 2007 Thomson - Wadsworth
Urea Cycle Disorders
• Adjunct therapiesLiver transplantationAlternative pathway therapy
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
27
© 2007 Thomson - Wadsworth
Mitochondrial Disorders
• Results from defects either in the respiratory chain or from defects affecting overall number and function of the mitochondria
• MELAS or NARP• See Table 28.9 for related conditions
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
28
© 2007 Thomson - Wadsworth
Mitochondrial Disorders
• DiagnosisDNA mutation testingSkin and muscle tissue histological and biochemical analysis
• Disorders includeFatty acid transport disordersFatty acid oxidation defectsPyruvate complex disordersRespiratory chain defects
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
29
© 2007 Thomson - Wadsworth
Mitochondrial Disorders
• Respiratory Chain Five complexes that undergo changes in their oxidative state to produce ATP• See Figure 28.4
Defects lead to:• Decreased energy production• Hypotonia, developmental delay, failure
to thrive
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
30
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
31
© 2007 Thomson - Wadsworth
Mitochondrial Disorders
• Nutrition InterventionNo definite treatmentUse of vitamin cofactors in pharmacological amounts – see Table 28.10• 100-1000 times DRI for age• Riboflavin and thiamin – cofactors• Vitamin E and lipoic acid – antioxidants• Vitamins C, K, CoQ10 – artificial electron receptors
and transporters
Frequent feedings recommended
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
32
© 2007 Thomson - Wadsworth
Mitochondrial Disorders
• Adjunct therapiesCarnitine and glycine – conjugate with toxic metabolites, removing them from body
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
33
© 2007 Thomson - Wadsworth
Disorders of Vitamin Metabolism
• Needed as cofactors for enzymatic reactions, antioxidants, or electron receptors
• Pharmacologic dose may be sufficient to maintain normal enzymatic function
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
34
© 2007 Thomson - Wadsworth
Disorders of Vitamin Metabolism
• Nutritional InterventionsMethylmalonic acidemia –responsive to B12
Holocarboxylase synthetasedeficiency and biotinidasedeficiency - responsive to biotin
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
35
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
36
© 2007 Thomson - Wadsworth
Disorders of Vitamin Metabolism
• Nutritional ConcernsPharmacological doses of vitamins should be treated as “drugs”Use of “megavitamin” supplements in random fashion discouragedToxicity a concern for fat-soluble vitaminsComplianceCost
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
37
© 2007 Thomson - Wadsworth
Disorders of Carbohydrate Metabolism
• Problems processing simple sugars galactose and fructose, or glycogen storage diseases
• Summary of disorders and clinical symptoms – see Table 28.11
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
38
© 2007 Thomson - Wadsworth
Galactosemia
• Enzyme defect in galactose metabolism leading to failure to thrive, hepatomegaly, life-threatening sepsis in newborn period
Vomiting, jaundice upon initiation of milk feedingsAnorexia, failure to gain weight or growCirrhosis, ascites, edema, bleeding problems, enlarged spleen if milk feedings continue
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
39
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
40
© 2007 Thomson - Wadsworth
Galactosemia
• Many states screen for it• Defect is in conversion of galactose
to glucose 1 phosphate• G1P accumulates in tissue• Clinical manifestations result
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
41
© 2007 Thomson - Wadsworth
Galactosemia
• Nutrition InterventionsExclusion of galactose/ lactose from diet• Immediate reversal of symptoms results
Exclusion of human milk, cow’s milk …Substitution of casein hydrolysate-containing formulaInfant soy formulasLearn other potential dietary and drug sources of galactose• See Table 28.12
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
42
© 2007 Thomson - Wadsworth
Galactosemia
• Nutrition concernsProvision of alternative sources of missing nutrients: vitamin D, calciumCalcium supplementsMeet kcal, protein, vitamin and mineral needs
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
43
© 2007 Thomson - Wadsworth
Hereditary Fructose Intolerance
• Deficiency of fructose 1 phosphate aldolase
• Accumulation in tissues containing fructokinase, causing depletion of inorganic phosphate and ATP
• Fructose-induced hypoglycemia• d/t ingestion of fructose, sucrose, or
sorbitol in diet
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
44
© 2007 Thomson - Wadsworth
Hereditary Fructose Intolerance
• Clinical manifestationsVomitingPoor feeding, diarrhea, failure to thriveHepatomegaly, bleeding tendency, jaundice, edema, ascites
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
45
© 2007 Thomson - Wadsworth
Hereditary Fructose Intolerance
• Nutrition InterventionWith fructose-free diet vomiting and bleeding tendency disappear immediatelyHepatomegaly and steatosis will disappear between 5-10 years
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
46
© 2007 Thomson - Wadsworth
Hereditary Fructose Intolerance
• Nutrition ConcernsVitamin supplement may be indicatedRequires strict avoidance for life of all dietary fructose and sucroseAversion to sweets may develop
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
47
© 2007 Thomson - Wadsworth
Glycogen Storage Diseases
• Deficiencies of enzymes that regulate the synthesis or degradation of glycogen (8 types)
• Most related to deficient activity in conversion of glycogen to glucose 6 phosphate
• Results in abnormal glycogen deposition in liver and muscle
See Table 28.13
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
48
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
49
© 2007 Thomson - Wadsworth
Glycogen Storage Diseases
• GSD1 most commonly diagnosed• Deficiency of enzyme glucose 6
phosphatase resulting in hypoglycemia• Low blood glucose results in short periods
of fasting (2-4 hours)• Elevations in lipids, lactate, uric acid• Hepatomegaly• Chronic lactic acidosis, poor growth• Osteoporotic bones, delayed bone age
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
50
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
51
© 2007 Thomson - Wadsworth
Glycogen Storage Diseases
• Nutrition Interventions – GSD1Frequent oral feedings, high in CHO to maintain glucose > 70 mg/dLDaytime meals followed by continuous drip nocturnal enteralfeedingsCornstarch - 1-2 g/kg body weight every 3-6 hours
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
52
© 2007 Thomson - Wadsworth
Glycogen Storage Diseases
• Nutrition Concerns – GSD1Availability of high-CHO snacks at all timesIllness can be life threateningAdjustment to decreased oral intakeMultivitamin/ mineral supplementCalcium and iron supplementation
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
53
© 2007 Thomson - Wadsworth
Disorders of Fat Metabolism
• Defect in enzymes which allows transport of fatty acids into the mitochondria; specific to short-, medium- or long-chain fatty acids
See Table 28.14 disorders
• Fatty acids not utilized resulting in hypoglycemia, hyperammonemia, death
• MCADD most common• Deficiencies of carnitine metabolism
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
54
© 2007 Thomson - Wadsworth
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
55
© 2007 Thomson - Wadsworth
Disorders of Fat Metabolism
• Nutrition InterventionPrevention of fastingLimiting intake of fatty acidsProviding alternate substrate for metabolism (CHO, protein)Include complex CHO vs. simple to maintain euglycemia
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
56
© 2007 Thomson - Wadsworth
Disorders of Fat Metabolism
• Nutrition InterventionLCHADD – restrict long-chain fatty acids to no more than 15% of kcalSupplement with MCTMCADD – avoidance of fasting, feed every 3 hoursMonitor blood glucose levelsDo not use MCT oil
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
57
© 2007 Thomson - Wadsworth
Disorders of Fat Metabolism
• Nutrition ConcernsOverrestriction of fatEssential fatty acid deficiencyExcessive weight gainMaximize fluid intakeCarnitine used to detoxify, given as supplement
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________